WUXI BIO is listed in Hong Kong. Sector: Healthcare. Industry: Biotechnology.
WUXI BIO (02269): research close 46.30 HKD on 2026-11-17. 52-week range 29.70 to 57.90 HKD. Sector: Healthcare. Historical research data, not advice.
| Fact | Figure | As of |
|---|---|---|
| Historical research close | 46.30 HKD | 2026-11-17 |
| Previous research close | 46.74 HKD | 2026-11-16 |
| Change between the two dated research closes | -0.94% | 2026-11-16 – 2026-11-17 |
| Market capitalisation | 190.63 billion HKD | 2026-11-17 |
| 52-week range of the research close | 29.70 – 57.90 HKD | 2025-11-18 – 2026-11-17 |
| One-year change in the research close | 43.08% | 2025-11-17 – 2026-11-17 |
| Average daily turnover (20 sessions) | 1.49 billion HKD | 2026-11-17 |
Source: hk_prices_research_v1 · HK · research close
Historical research prices; adjustments vary by market. This is not a live quote or a forecast.
Members can compare available company evidence and explicitly save 02269 to a watchlist. A company is saved only after Save is pressed for it.
Free membership opens nine research tools, starting with the Hotlist: the stocks drawing unusual turnover each session.
Nine member offerings. Free. No card.
Join freeResearch, not advice.
Glossary: AVWAP · Date of Control · Beta · Loading · Market cap · Cost of equity · Implied rate